Note that, in persons who haven't had a heart attack, daily aspirin does reduce heart attack risk in exchange for risk of major bleeding. https://www.ncbi.nlm.n

Note that, in persons who haven't had a heart attack, daily aspirin does reduce heart attack risk in exchange for risk of major bleeding. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439678/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439678/ Its effect on mortality, then? A wash. https://www.acpjournals.org/doi/10.7326/M15-2113 https://www.acpjournals.org/doi/10.7326/M15-2113 >Clinical trials of aspirin in patients without cardiovascular disease have inconsistently demonstrated improvements in cardiovascular outcomes, with potential benefits countered by increased risks of clinically significant bleeding. The uncertain role of aspirin in primary prevention of cardiovascular events is reflected in contrasting recommendations offered by guideline bodies. The overall effect of this uncertainty has been a decline in aspirin prescribing for primary prevention over the past 5 to 10 years.